The Blood Pressure "Uncertainty Range" – a pragmatic approach to overcome current diagnostic uncertainties (II)
<p>Abstract</p> <p>A tremendous amount of scientific evidence regarding the physiology and physiopathology of high blood pressure combined with a sophisticated therapeutic arsenal is at the disposal of the medical community to counteract the overall public health burden of hyperten...
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2005-04-01
|
| Series: | Current Controlled Trials in Cardiovascular Medicine |
| Online Access: | http://cvm.controlled-trials.com/content/6/1/5 |
| _version_ | 1819182251288559616 |
|---|---|
| author | Pater Cornel |
| author_facet | Pater Cornel |
| author_sort | Pater Cornel |
| collection | DOAJ |
| description | <p>Abstract</p> <p>A tremendous amount of scientific evidence regarding the physiology and physiopathology of high blood pressure combined with a sophisticated therapeutic arsenal is at the disposal of the medical community to counteract the overall public health burden of hypertension. Ample evidence has also been gathered from a multitude of large-scale randomized trials indicating the beneficial effects of current treatment strategies in terms of reduced hypertension-related morbidity and mortality.</p> <p>In spite of these impressive advances and, deeply disappointingly from a public health perspective, the real picture of <it>hypertension management </it>is overshadowed by widespread diagnostic inaccuracies (underdiagnosis, overdiagnosis) as well as by treatment failures generated by undertreatment, overtreatment, and misuse of medications.</p> <p>The scientific, medical and patient communities as well as decision-makers worldwide are striving for greatest possible health gains from available resources.</p> <p>A seemingly well-crystallised reasoning is that comprehensive strategic approaches must not only target hypertension as a pathological entity, but rather, take into account the wider environment in which hypertension is a major risk factor for cardiovascular disease carrying a great deal of our inheritance, and its interplay in the constellation of other, well-known, modifiable risk factors, i.e., attention is to be switched from one's "blood pressure level" to one's absolute cardiovascular risk and its determinants. Likewise, a risk/benefit assessment in each individual case is required in order to achieve best possible results.</p> <p>Nevertheless, it is of paramount importance to insure generalizability of ABPM use in clinical practice with the aim of improving the accuracy of a first diagnosis for both individual treatment and clinical research purposes. Widespread adoption of the method requires quick adjustment of current guidelines, development of appropriate technology infrastructure and training of staff (i.e., education, decision support, and information systems for practitioners and patients). Progress can be achieved in a few years, or in the next 25 years.</p> |
| first_indexed | 2024-12-22T22:43:09Z |
| format | Article |
| id | doaj.art-df53beaeaead4a37b0da8be2fb873cba |
| institution | Directory Open Access Journal |
| issn | 1468-6708 |
| language | English |
| last_indexed | 2024-12-22T22:43:09Z |
| publishDate | 2005-04-01 |
| publisher | BMC |
| record_format | Article |
| series | Current Controlled Trials in Cardiovascular Medicine |
| spelling | doaj.art-df53beaeaead4a37b0da8be2fb873cba2022-12-21T18:10:09ZengBMCCurrent Controlled Trials in Cardiovascular Medicine1468-67082005-04-0161510.1186/1468-6708-6-5The Blood Pressure "Uncertainty Range" – a pragmatic approach to overcome current diagnostic uncertainties (II)Pater Cornel<p>Abstract</p> <p>A tremendous amount of scientific evidence regarding the physiology and physiopathology of high blood pressure combined with a sophisticated therapeutic arsenal is at the disposal of the medical community to counteract the overall public health burden of hypertension. Ample evidence has also been gathered from a multitude of large-scale randomized trials indicating the beneficial effects of current treatment strategies in terms of reduced hypertension-related morbidity and mortality.</p> <p>In spite of these impressive advances and, deeply disappointingly from a public health perspective, the real picture of <it>hypertension management </it>is overshadowed by widespread diagnostic inaccuracies (underdiagnosis, overdiagnosis) as well as by treatment failures generated by undertreatment, overtreatment, and misuse of medications.</p> <p>The scientific, medical and patient communities as well as decision-makers worldwide are striving for greatest possible health gains from available resources.</p> <p>A seemingly well-crystallised reasoning is that comprehensive strategic approaches must not only target hypertension as a pathological entity, but rather, take into account the wider environment in which hypertension is a major risk factor for cardiovascular disease carrying a great deal of our inheritance, and its interplay in the constellation of other, well-known, modifiable risk factors, i.e., attention is to be switched from one's "blood pressure level" to one's absolute cardiovascular risk and its determinants. Likewise, a risk/benefit assessment in each individual case is required in order to achieve best possible results.</p> <p>Nevertheless, it is of paramount importance to insure generalizability of ABPM use in clinical practice with the aim of improving the accuracy of a first diagnosis for both individual treatment and clinical research purposes. Widespread adoption of the method requires quick adjustment of current guidelines, development of appropriate technology infrastructure and training of staff (i.e., education, decision support, and information systems for practitioners and patients). Progress can be achieved in a few years, or in the next 25 years.</p>http://cvm.controlled-trials.com/content/6/1/5 |
| spellingShingle | Pater Cornel The Blood Pressure "Uncertainty Range" – a pragmatic approach to overcome current diagnostic uncertainties (II) Current Controlled Trials in Cardiovascular Medicine |
| title | The Blood Pressure "Uncertainty Range" – a pragmatic approach to overcome current diagnostic uncertainties (II) |
| title_full | The Blood Pressure "Uncertainty Range" – a pragmatic approach to overcome current diagnostic uncertainties (II) |
| title_fullStr | The Blood Pressure "Uncertainty Range" – a pragmatic approach to overcome current diagnostic uncertainties (II) |
| title_full_unstemmed | The Blood Pressure "Uncertainty Range" – a pragmatic approach to overcome current diagnostic uncertainties (II) |
| title_short | The Blood Pressure "Uncertainty Range" – a pragmatic approach to overcome current diagnostic uncertainties (II) |
| title_sort | blood pressure uncertainty range a pragmatic approach to overcome current diagnostic uncertainties ii |
| url | http://cvm.controlled-trials.com/content/6/1/5 |
| work_keys_str_mv | AT patercornel thebloodpressureuncertaintyrangeapragmaticapproachtoovercomecurrentdiagnosticuncertaintiesii AT patercornel bloodpressureuncertaintyrangeapragmaticapproachtoovercomecurrentdiagnosticuncertaintiesii |